Aiml Resources (42FB) AI Stock Analysis

Aiml Resources

(Frankfurt:42FB)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Positive EPS GrowthReported EPS growth provides some evidence of improvement in per-share performance despite the company remaining deeply loss-making. If sustained, this could support eventual stabilization, although the current losses mean the improvement has not yet translated into positive earnings or financial self-sufficiency.

Negative Factors

Shrinking Revenue and Negative Gross ProfitExtremely small and declining revenue limits the company’s operating scale and ability to absorb fixed costs. Negative gross profit shows that current sales do not cover direct costs, indicating deteriorating unit economics and making a durable path to profitability difficult without material improvement.

Aiml Resources (42FB) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 13.43M
Dividend Yield: ―
Average Volume (3M): 638
Price to Earnings (P/E): -1.7
Beta (1Y): 1.42
Revenue Growth: -75.43%
EPS Growth: 27.35%
Country: Germany
Employees: 3
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Healthcare Information Services

Aiml Resources Business Overview & Revenue Model

Company Description

Operating within the digital healthcare sector, AI/ML Innovations Inc. harnesses the power of artificial intelligence (AI) and machine learning (ML). The company's central offering is a patent-pending system for personal health monitoring and managem...

Aiml Resources Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:42FB against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:CHS	41Neutral	CAD 10.29M	-1.76	64.52%	―	7.63%	-106.03%
TSE:UDOC	41Neutral	CAD 5.18M	-1.46	355.56%	―	614.03%	51.97%
TSE:DMED	39Underperform	CAD 3.95M	-1.94	739.84%	―	―	-28.35%
TSE:ADK	38Underperform	CAD 40.34M	-8.47	9999.00%	―	-36.92%	13.03%
TSE:NARA	38Underperform	CAD 2.39M	-0.82	184.91%	―	―	43.30%

* Healthcare Sector Average

Performance Comparison

DE:42FB and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:42FB	Aiml Resources Inc.	0.02	-0.01	-20.69%
TSE:ADK	Diagnos Inc	0.35	0.03	9.37%
TSE:CHS	Comprehensive Healthcare Systems Inc	0.33	-0.26	-44.07%
TSE:UDOC	Unidoc Health Corp.	0.06	-0.15	-72.50%
TSE:NARA	PanGenomic Health, Inc. Class A	0.17	-1.03	-85.83%
TSE:DMED	DiagnaMed Holdings Corp.	0.03	-0.06	-64.71%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Aiml Resources AI Stock Analysis